DAM
YARW

Deltec Asset Management’s Yarrow Bioscience YARW Stock Holding History

Deltec Asset Management’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-33
Closed -$4.5K – 184
2022
Q4 		$4.5K Hold
33
– – ﹤0.01% 164
2022
Q3 		$7K Hold
33
– – ﹤0.01% 224
2022
Q2 		$12K Hold
33
– – ﹤0.01% 234
2022
Q1 		$20K Hold
33
– – ﹤0.01% 257
2021
Q4 		$31K Hold
33
– – 0.01% 254
2021
Q3 		$42K Sell
33
-396
-92% -$768K 0.01% 273
2021
Q2 		$1.36M Sell
429
-62
-13% -$245K 0.19% 85
2021
Q1 		$3.02M Sell
491
-91
-16% -$660K 0.45% 50
2020
Q4 		$3.31M Buy
+582
New +$3.66M 0.51% 50

Other funds holding YARW

DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCA
STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.57B AUM 26.96% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Deltec Asset Management's YARW Position: Q1 2023 in Review

Deltec Asset Management sold out of Yarrow Bioscience (YARW) in Q1 2023, closing a stake of 33 shares — an estimated $4.5K sold.

Deltec Asset Management first reported a position in YARW in Q4 2020 and held it in 9 quarters. The position peaked at $3.31M in Q4 2020. 21 funds tracked by Wall St. Rank hold YARW as of Q1 2023.

  • Deltec Asset Management reported no remaining Yarrow Bioscience position as of Q1 2023 after selling out during the quarter.
  • Deltec Asset Management sold 33 Yarrow Bioscience shares in Q1 2023, an estimated $4.5K.
  • Deltec Asset Management first reported a position in Yarrow Bioscience in Q4 2020 and held it in 9 quarters.
  • Deltec Asset Management's Yarrow Bioscience position peaked at $3.31M in Q4 2020.
  • 21 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q1 2023.

Based on Deltec Asset Management's 13F filing for Q1 2023, filed 17 Apr 2023.